 BRIDGEWATER, N.J.--BUSINESS WIRE--Amneal Pharmaceuticals, Inc. the Company NYSE:AMRX and Kashiv BioSciences LLC Kashiv today announced they have entered into a definitive agreement under which Amneal Pharmaceuticals LLC Amneal, a wholly-owned subsidiary of the Company, will acquire a 98 interest in Kashiv Specialty Pharmaceuticals, LLC Kashiv Specialty, a wholly-owned subsidiary of Kashiv focused on the development of complex generics, innovative drug delivery platforms and 